Autres langues Krystal Biotech, Inc.

Actions

KRYS

US5011471027

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 18/04/2024			Varia. 5j.	Varia. 1 janv.
164 ^USD	-3,34 %		-8,88 %	+32,17 %

16/04	KRYSTAL BIOTECH, INC. : Stifel Nicolaus réitère son opinion positive sur le titre	ZM
12/03	Un initié de Krystal Biotech a vendu des actions pour une valeur de 8 547 719 $, selon un récent dépôt auprès de la SEC	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting	05/04
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting	04/04
Krystal Biotech Insider Sold Shares Worth $8,547,719, According to a Recent SEC Filing	12/03
Krystal Biotech Insider Sold Shares Worth $8,547,719, According to a Recent SEC Filing	12/03
Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference	29/02
Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference	28/02
Sector Update: Health Care Stocks Ease Late Afternoon	26/02
Sector Update: Health Care Stocks Weaker Monday Afternoon	26/02
Top Midday Gainers	26/02
Krystal Biotech Shares Jump After Surprise Q4 Profit	26/02
Krystal Biotech Swings to Q4 Profit as Company Generates Revenue; Shares Climb Pre-Bell	26/02
Krystal Biotech, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	26/02
Earnings Flash (KRYS) KRYSTAL BIOTECH Posts Q4 EPS $0.30, vs. Street Est of $-0.25	26/02
Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates	26/02
Krystal Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02
North American Morning Briefing : Traders Await Inflation Data This Week	26/02
MORNING BID AMERICAS-Booming stocks step back as PCE hoves into view	26/02
Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024	21/02
Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024	20/02
Cystic Fibrosis Pipeline Insights Report 2024 \| Krystal Biotech, Vertex Pharmaceuticals, Translate Bio, Novartis, and others.	19/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Krystal Biotech, Inc.

Actions

KRYS

US5011471027

Autres langues

Filtres